• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺腺鳞癌是腺癌和鳞癌的简单混合,还是在分子水平上更复杂?

Are adenosquamous lung carcinomas a simple mix of adenocarcinomas and squamous cell carcinomas, or more complex at the molecular level?

机构信息

CEA, DSV, IRCM, SREIT, Laboratoire de Cancérologie Expérimentale, BP6, Fontenay-aux-Roses Cedex F-92265, France.

出版信息

Lung Cancer. 2010 Apr;68(1):1-9. doi: 10.1016/j.lungcan.2009.11.001. Epub 2009 Dec 8.

DOI:10.1016/j.lungcan.2009.11.001
PMID:20004040
Abstract

Adenocarcinomas (AC), squamous cell carcinomas (SCC) and adenosquamous carcinomas (ASC) are three histological subtypes of non-small-cell lung carcinomas (NSCLC). ASC are morphologically mixed tumours that contain the two cell components AC and SCC. To understand if they are a "simple" mix of AC and SCC or if they present molecular specificities, as compared with the molecular characterization of both components, we performed a comparative transcriptome analysis on a series of nine ASC, five AC and five SCC induced in rats by radon exposure. We found that 72, 40 and 39 genes were differentially expressed when comparing AC_SCC, ASC_SCC and AC_ASC, respectively. Moreover, when classifying the three histological subtypes, using genes that discriminated AC and SCC, we observed that all ASC were classified as intermediate between the AC and SCC, some being closer to AC, others to SCC. These results indicated that, regarding gene expression, ASC could be considered as a mix of AC and SCC, both in various proportions. However, they also exhibit molecular specificities since we found specific genes discriminating ASC_SCC and AC_ASC. In conclusion, the ASC mixed lung tumours are more complex than simple mixes of AC and SCC components. Neuroendocrine differentiation and ERK proliferation pathways seemed preferentially deregulated in ASC compared to AC and SCC respectively, pathways that are worthy of being explored because they could partially explain the high clinical aggressiveness of ASC.

摘要

腺鳞癌(AC)、鳞状细胞癌(SCC)和腺鳞癌(ASC)是非小细胞肺癌(NSCLC)的三种组织学亚型。ASC 是形态混合的肿瘤,包含 AC 和 SCC 两种细胞成分。为了了解它们是 AC 和 SCC 的“简单”混合物,还是与两种成分的分子特征相比具有分子特异性,我们对氡暴露诱导的大鼠 9 例 ASC、5 例 AC 和 5 例 SCC 进行了比较转录组分析。我们发现,当比较 AC_SCC、ASC_SCC 和 AC_ASC 时,分别有 72、40 和 39 个基因差异表达。此外,当使用区分 AC 和 SCC 的基因对三种组织学亚型进行分类时,我们观察到所有 ASC 都被分类为 AC 和 SCC 之间的中间型,有些更接近 AC,有些更接近 SCC。这些结果表明,就基因表达而言,ASC 可以被认为是 AC 和 SCC 的混合物,比例各不相同。然而,它们也表现出分子特异性,因为我们发现了区分 ASC_SCC 和 AC_ASC 的特定基因。总之,ASC 混合肺肿瘤比 AC 和 SCC 成分的简单混合物更复杂。与 AC 和 SCC 相比,神经内分泌分化和 ERK 增殖途径似乎在 ASC 中优先失调,这些途径值得进一步研究,因为它们可能部分解释了 ASC 较高的临床侵袭性。

相似文献

1
Are adenosquamous lung carcinomas a simple mix of adenocarcinomas and squamous cell carcinomas, or more complex at the molecular level?肺腺鳞癌是腺癌和鳞癌的简单混合,还是在分子水平上更复杂?
Lung Cancer. 2010 Apr;68(1):1-9. doi: 10.1016/j.lungcan.2009.11.001. Epub 2009 Dec 8.
2
Differential ErbB receptor expression and intracellular signaling activity in lung adenocarcinomas and squamous cell carcinomas.肺腺癌和肺鳞状细胞癌中表皮生长因子受体(ErbB)的差异表达及细胞内信号传导活性
Lung Cancer. 2009 Jul;65(1):25-33. doi: 10.1016/j.lungcan.2008.10.009. Epub 2008 Nov 28.
3
Protein expression profiles of non-small cell lung carcinomas: correlation with histological subtype.非小细胞肺癌的蛋白质表达谱:与组织学亚型的相关性
Anticancer Res. 2002 Jul-Aug;22(4):2321-4.
4
Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung carcinoma.密码子72 p53和谷胱甘肽S-转移酶M1(GSTM1)基因多态性与非小细胞肺癌组织学亚型的差异关联。
Cancer Res. 2001 Dec 15;61(24):8718-22.
5
Expression of phosphatase and tensin homolog and programmed cell death ligand 1 in adenosquamous carcinoma of the lung.磷酸酶张力蛋白同系物和程序性细胞死亡配体 1 在肺的腺鳞癌中的表达。
Biochem Biophys Res Commun. 2018 Sep 18;503(4):2764-2769. doi: 10.1016/j.bbrc.2018.08.037. Epub 2018 Aug 9.
6
Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.肺鳞状细胞癌中K-ras癌基因的突变及H-ras突变的缺失
Clin Cancer Res. 1995 Mar;1(3):359-65.
7
Expression of cell proliferating genes in patients with non-small cell lung cancer by immunohistochemistry and cDNA profiling.通过免疫组织化学和cDNA分析检测非小细胞肺癌患者细胞增殖基因的表达
Oncol Rep. 2005 May;13(5):837-46.
8
Adenosquamous carcinoma of the lung: surgical management, pathologic characteristics, and prognostic implications.肺的腺鳞癌:外科治疗、病理特征和预后意义。
Ann Thorac Surg. 2013 Apr;95(4):1189-95. doi: 10.1016/j.athoracsur.2012.12.037. Epub 2013 Mar 6.
9
Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes.全球基因表达分析揭示了非小细胞肺癌亚型中细胞连接的特定模式。
Lung Cancer. 2009 Jan;63(1):32-8. doi: 10.1016/j.lungcan.2008.03.033. Epub 2008 May 16.
10
Transition from squamous cell carcinoma to adenocarcinoma in adenosquamous carcinoma of the lung.肺腺鳞癌中从鳞状细胞癌向腺癌的转变。
Am J Pathol. 2000 Apr;156(4):1289-98. doi: 10.1016/S0002-9440(10)64999-1.

引用本文的文献

1
Clonal dynamics and Stereo-seq resolve origin and phenotypic plasticity of adenosquamous carcinoma.克隆动力学和空间转录组测序解析腺鳞癌的起源和表型可塑性。
NPJ Precis Oncol. 2023 Aug 26;7(1):80. doi: 10.1038/s41698-023-00430-8.
2
Transformation of adenocarcinoma to squamous cell carcinoma as a source of EGFR-TKI resistance: A case report and literature review.腺癌向鳞状细胞癌转化作为表皮生长因子受体酪氨酸激酶抑制剂耐药的一个来源:一例病例报告及文献综述
Front Oncol. 2022 Sep 8;12:942084. doi: 10.3389/fonc.2022.942084. eCollection 2022.
3
Inspirations of Cobalt Oxide Nanoparticle Based Anticancer Therapeutics.
基于氧化钴纳米颗粒的抗癌疗法的启示
Pharmaceutics. 2021 Oct 2;13(10):1599. doi: 10.3390/pharmaceutics13101599.
4
Adenocarcinomatous-predominant subtype associated with a better prognosis in adenosquamous lung carcinoma.富含腺癌成分的肺鳞腺癌亚型与更好的预后相关。
BMC Cancer. 2020 Jun 5;20(1):520. doi: 10.1186/s12885-020-06972-5.
5
Research progress of the clinicopathologic features of lung adenosquamous carcinoma.肺腺鳞癌临床病理特征的研究进展
Onco Targets Ther. 2018 Oct 16;11:7011-7017. doi: 10.2147/OTT.S179904. eCollection 2018.
6
Adenosquamous carcinoma of the lung.肺腺鳞癌
Onco Targets Ther. 2018 Aug 14;11:4829-4835. doi: 10.2147/OTT.S164574. eCollection 2018.
7
Surgical significance and efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in patients with primary lung adenosquamous carcinoma.表皮生长因子受体酪氨酸激酶抑制剂在原发性肺腺鳞癌患者中的手术意义及疗效
Cancer Manag Res. 2018 Aug 2;10:2401-2407. doi: 10.2147/CMAR.S165660. eCollection 2018.
8
[Clinicopathologic Features and Prognostic Implications in 72 Cases 
with Lung Adenosquamous Carcinoma].72例肺腺鳞癌的临床病理特征及预后意义
Zhongguo Fei Ai Za Zhi. 2016 Oct 20;19(10):653-658. doi: 10.3779/j.issn.1009-3419.2016.10.03.
9
Predictive and prognostic value of preoperative serum tumor markers in resectable adenosqamous lung carcinoma.术前血清肿瘤标志物在可切除腺鳞癌中的预测和预后价值
Oncotarget. 2016 Oct 4;7(40):64798-64809. doi: 10.18632/oncotarget.11703.
10
Histologic Transformation from Adenocarcinoma to Squamous Cell Carcinoma as a Mechanism of Resistance to EGFR Inhibition.腺癌向鳞状细胞癌的组织学转化作为对表皮生长因子受体(EGFR)抑制产生耐药的一种机制。
J Thorac Oncol. 2015 Sep;10(9):e86-e88. doi: 10.1097/JTO.0000000000000571.